<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1006748.ref055">
 <label>55</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Her</surname>
   <given-names>Z</given-names>
  </name>, 
  <name>
   <surname>Teng</surname>
   <given-names>TS</given-names>
  </name>, 
  <name>
   <surname>Tan</surname>
   <given-names>JJ</given-names>
  </name>, 
  <name>
   <surname>Teo</surname>
   <given-names>TH</given-names>
  </name>, 
  <name>
   <surname>Kam</surname>
   <given-names>YW</given-names>
  </name>, 
  <name>
   <surname>Lum</surname>
   <given-names>FM</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response</article-title>. 
  <source>EMBO Mol Med</source>. 
  <year>2014</year>;
  <volume>7</volume>(
  <issue>1</issue>):
  <fpage>24</fpage>â€“
  <lpage>41</lpage>. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.15252/emmm.201404459" xmlns:xlink="http://www.w3.org/1999/xlink">10.15252/emmm.201404459</ext-link>
  </comment> .
  <?supplied-pmid 25452586?>
  <pub-id pub-id-type="pmid">25452586</pub-id>
 </mixed-citation>
</ref>
